Patient and public involvement in the build-up of COVID-19 testing in Sweden.

COVID-19 pandemic COVID-19 testing Sweden patient and public involvement

Journal

Health expectations : an international journal of public participation in health care and health policy
ISSN: 1369-7625
Titre abrégé: Health Expect
Pays: England
ID NLM: 9815926

Informations de publication

Date de publication:
04 2022
Historique:
revised: 11 02 2022
received: 06 06 2021
accepted: 18 02 2022
pubmed: 9 3 2022
medline: 1 4 2022
entrez: 8 3 2022
Statut: ppublish

Résumé

Patient and public involvement in healthcare can be particularly challenging during crises such as the COVID-19 pandemic. The aims of the study, which focuses on COVID-19 testing in Sweden, were to explore (1) how, or to what extent, patients and members of the public were involved in decisions about the organization of COVID-19 testing during the first year of pandemic and (2) whether this was seen as feasible or desirable by regional and national stakeholders. A qualitative interview study was conducted with key organizational stakeholders at three national agencies and within three Swedish regions (n = 16). There had been no patient and public involvement activities in the area of COVID-19 testing. The regions had, however, tried to respond to demands or critiques from patients and the public along the way and to adapt the services to respond to their preferences. The need for rapid decision-making, the uncertainty about whom to involve, as well as a hesitation about the appropriateness of involving patients and the public contributed to the lack of involvement. Future studies on patient and public involvement during crises should address what structures need to be in place to carry out involvement successfully during crises and when to use activities with varying degrees of power or decision-making authority for patients and members of the public. Fifteen members of the public contributed with short reflections on the study findings.

Sections du résumé

BACKGROUND
Patient and public involvement in healthcare can be particularly challenging during crises such as the COVID-19 pandemic.
OBJECTIVE
The aims of the study, which focuses on COVID-19 testing in Sweden, were to explore (1) how, or to what extent, patients and members of the public were involved in decisions about the organization of COVID-19 testing during the first year of pandemic and (2) whether this was seen as feasible or desirable by regional and national stakeholders.
METHODS
A qualitative interview study was conducted with key organizational stakeholders at three national agencies and within three Swedish regions (n = 16).
RESULTS
There had been no patient and public involvement activities in the area of COVID-19 testing. The regions had, however, tried to respond to demands or critiques from patients and the public along the way and to adapt the services to respond to their preferences. The need for rapid decision-making, the uncertainty about whom to involve, as well as a hesitation about the appropriateness of involving patients and the public contributed to the lack of involvement.
CONCLUSION
Future studies on patient and public involvement during crises should address what structures need to be in place to carry out involvement successfully during crises and when to use activities with varying degrees of power or decision-making authority for patients and members of the public.
PATIENT OR PUBLIC CONTRIBUTION
Fifteen members of the public contributed with short reflections on the study findings.

Identifiants

pubmed: 35257448
doi: 10.1111/hex.13463
pmc: PMC8957722
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

541-548

Subventions

Organisme : The Swedish Research Council for Health, Working Life and Welfare
ID : 2018-01578

Informations de copyright

© 2022 The Authors. Health Expectations published by John Wiley & Sons Ltd.

Références

Am J Respir Crit Care Med. 2018 Aug 1;198(3):310-319
pubmed: 29624408
PLoS One. 2018 Mar 2;13(3):e0193579
pubmed: 29499043
Health Aff (Millwood). 2013 Feb;32(2):223-31
pubmed: 23381514
Health Expect. 2022 Apr;25(2):477-481
pubmed: 34773337
Res Involv Engagem. 2019 Nov 4;5:31
pubmed: 31700675
Health Expect. 2022 Apr;25(2):541-548
pubmed: 35257448
Health Expect. 2019 Aug;22(4):607-608
pubmed: 31508884
Health Res Policy Syst. 2021 Jan 20;19(1):8
pubmed: 33472647
Health Expect. 2021 Dec;24(6):1903-1904
pubmed: 34420243
Med Decis Making. 2011 Nov-Dec;31(6):E45-74
pubmed: 21959267
PLoS One. 2021 May 6;16(5):e0250614
pubmed: 33956831
Patient. 2020 Jun;13(3):255
pubmed: 32301034
Soc Sci Med. 2002 Jun;54(12):1825-37
pubmed: 12113438
PLoS One. 2021 Sep 29;16(9):e0257880
pubmed: 34587175
Disaster Med Public Health Prep. 2013 Oct;7(5):534-40
pubmed: 24274133
BMJ. 2020 Jul 1;370:m2575
pubmed: 32611571

Auteurs

Mio Fredriksson (M)

Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH